BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Vitamin E
,
rs3825942
,
PDX1
,
Angiogenesis
,
Leukemia
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SR26334
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A pharmacokinetics interaction study of antiplatelet agents aspirin and clopidogrel combined with dl…
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalic…
Impact of clopidogrel carboxylic metabolite SR26334 on gene expression profile of human umbilical ve…
Influence of genetic and non-genetic factors on the plasma concentrations of the clopidogrel metabol…
Comparative bioavailability of two oral formulations of clopidogrel: determination of clopidogrel an…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavail…
Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses …
Clopidogrel Bioequivalence Study in Healthy Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ